Potential neurochemical links between cholesterol and suicidal behavior

Psychiatry Research

Volumn 220, Issue 3, 2014, Pages 745-751

  da Graça Cantarelli, Maria ^a   Tramontina, Ana Carolina ^b   Leite, Marina C ^a   Gonçalves, Carlos Alberto ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE ESTADUAL DO RIO GRANDE DO SUL   (Brazil)

Author keywords

Astrocyte; BDNF; Cholesterol; Lipid rafts; S100B protein; Serotonin; Suicidal behavior

Indexed keywords

ABC TRANSPORTER G1; CHOLESTEROL; CORTICOSTEROID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; NEUROSTEROID; SEROTONIN 1A RECEPTOR; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; SEROTONIN;

AGGRESSION; ASTROCYTE; BRAIN REGION; CELL MIGRATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; ENDOCYTOSIS; ENZYME SYNTHESIS; LIPID COMPOSITION; LIPID RAFT; MICROGLIA; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; OLIGODENDROGLIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SUICIDAL BEHAVIOR; SYNAPTIC MEMBRANE; BLOOD; BRAIN; HUMAN; MENTAL DISORDERS; METABOLISM; PSYCHOLOGY; SUICIDAL IDEATION; SUICIDE;

BIOLOGICAL MARKERS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHOLESTEROL; HUMANS; MENTAL DISORDERS; SEROTONIN; SUICIDAL IDEATION; SUICIDE;

EID: 84919844646     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.10.017     Document Type: Review

References (116)

1. Adkins E.M., Samuvel D.J., Fog J.U., Eriksen J., Jayanthi L.D., Vaegter C.B., Ramamoorthy S., Gether U. Membrane mobility and microdomain association of the dopamine transporter studied with fluorescence correlation spectroscopy and fluorescence recovery after photobleaching. Biochemistry 2007, 46:10484-10497.
2. Agargun M.Y., Ozer O.A., Kara H., Sekeroglu R., Selvi Y., Eryonucu B. Serum lipid levels in patients with dissociative disorder. The American Journal of Psychiatry 2004, 161:2121-2123.
3. Almeida-Montes L.G., Valles-Sanchez V., Moreno-Aguilar J., Chavez-Balderas R.A., García-Marín J.A., Cortés Sotres J.F., Hheinze-Martin G. Relation of serum cholesterol, lipid, serotonin and tryptophan levels to severity of depression and to suicide attempts. Journal of Psychiatry & Neuroscience: JPN 2000, 25:371-377.
4. Apter A., Laufer N., Bar-Sever M., Har-Even D., Ofek H., Weizman A. Serum cholesterol, suicidal tendencies, impulsivity, aggression, and depression in adolescent psychiatric inpatients. Biological Psychiatry 1999, 46:532-541.
5. Atmaca M., Kuloglu M., Tezcan E., Ustundag B. Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts. Acta Psychiatrica Scandinavica 2003, 108:208-214.
6. Atmaca M., Kuloglu M., Tezcan E., Ustundag B. Serum leptin and cholesterol values in violent and non-violent suicide attempters. Psychiatry Research 2008, 158:87-91.
7. Atmaca M., Tezcan E., Parmaksiz S., Saribas M., Ozler S., Ustundag B. Serum ghrelin and cholesterol values in suicide attempters. Neuropsychobiology 2006, 54:59-63.
8. Baek J.H., Kang E.-S., Fava M., Mischoulon D., Nierenberg A.A., Yu B.-H., Lee D., Jeon H.J. Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2014, 51:113-118.
9. Ballerini P., Ciccarelli R., Di Iorio P., Buccella S., D'Alimonte I., Giuliani P., Masciulli A., Nargi E., Beraudi A., Rathbone M.P., Caciagli F. Guanosine effect on cholesterol efflux and apolipoprotein E expression in astrocytes. Purinergic Signalling 2006, 2:637-649.
10. Biagini G., Longo D., Baldelli E., Zoli M., Rogawski M.A., Bertazzoni G., Avoli M. Neurosteroids and epileptogenesis in the pilocarpine model: evidence for a relationship between P450scc induction and length of the latent period. Epilepsia 2009, 50(Suppl 1):S53-S58.
11. Birger M., Swartz M., Cohen D., Alesh Y., Grishpan C., Kotelr M. Aggression: the testosterone-serotonin link. The Israel Medical Association Journal: IMAJ 2003, 5:653-658.
12. Booij L., Tremblay R.E., Leyton M., Séguin J.R., Vitaro F., Gravel P., Perreau-Linck E., Lévesque M.L., Durand F., Diksic M., Turecki G., Benkelfat C. Brain serotonin synthesis in adult males characterized by physical aggression during childhood: a 21-year longitudinal study. PLoS One 2010, 5:e11255.
13. Boscarino J.A., Erlich P.M., Hoffman S.N. Low serum cholesterol and external-cause mortality: potential implications for research and surveillance. Journal of Psychiatric Research 2009, 43:848-854.
14. Cedazo-Mínguez A., Hamker U., Meske V., Veh R.W., Hellweg R., Jacobi C., Albert F., Cowburn R.F., Ohm T.G. Regulation of apolipoprotein E secretion in rat primary hippocampal astrocyte cultures. Neuroscience 2001, 105:651-661.
15. Chen Z., Peto R., Collins R., MacMahon S., Lu J., Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ (Clinical Research Ed.) 1991, 303:276-282.
16. Corrêa H., Duval F., Mokrani M., Bailey P., Trémeau F., Staner L., Diep T.S., Hodé Y., Crocq M.A., Macher J.P. Prolactin response to d-fenfluramine and suicidal behavior in depressed patients. Psychiatry Research 2000, 93:189-199.
17. Coryell W., Schlesser M. The dexamethasone suppression test and suicide prediction. The American Journal of Psychiatry 2001, 158:748-753.
18. Dayton S., Pearce M.L. Diet and cardiovascular diseases. Lancet 1969, 1:51-52.
19. De Leon J., Mallory P., Maw L., Susce M.T., Perez-Rodriguez M.M., Baca-Garcia E. Lack of replication of the association of low serum cholesterol and attempted suicide in another country raises more questions. Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 2011, 23:163-170.
20. DeBarber A.E., Eroglu Y., Merkens L.S., Pappu A.S., Steiner R.D. Smith-Lemli-Opitz syndrome. Expert Reviews in Molecular Medicine 2011, 13:e24.
21. Deisenhammer E.A., Kramer-Reinstadler K., Liensberger D., Kemmler G., Hinterhuber H., Fleischhacker W.W. No evidence for an association between serum cholesterol and the course of depression and suicidality. Psychiatry Research 2004, 121:253-261.
22. Deveci A., Aydemir O., Taskin O., Taneli F., Esen-Danaci A. Serum BDNF levels in suicide attempters related to psychosocial stressors: a comparative study with depression. Neuropsychobiology 2007, 56:93-97.
23. Dietschy J.M. Central nervous system: cholesterol turnover, brain development and neurodegeneration. Biological Chemistry 2009, 390:287-293.
24. Donato R., Sorci G., Riuzzi F., Arcuri C., Bianchi R., Brozzi F., Tubaro C., Giambanco I. S100B's double life: intracellular regulator and extracellular signal. Biochimica et Biophysica Acta 2009, 1793:1008-1022.
25. Ellison L.F., Morrison H.I. Low serum cholesterol concentration and risk of suicide. Epidemiology (Cambridge, Mass.) 2001, 12:168-172.
26. Epand R.M., Sayer B.G., Epand R.F. Caveolin scaffolding region and cholesterol-rich domains in membranes. Journal of Molecular Biology 2005, 345:339-350.
27. Falcone T., Fazio V., Lee C., Simon B., Franco K., Marchi N., Janigro D. Serum S100B: a potential biomarker for suicidality in adolescents?. PLoS One 2010, 5:e11089.
28. Favaro A., Caregaro L., Di Pascoli L., Brambilla F., Santonastaso P. Total serum cholesterol and suicidality in anorexia nervosa. Psychosomatic Medicine 2004, 66:548-552.
29. Fiedorowicz J.G., Coryell W.H. Cholesterol and suicide attempts: a prospective study of depressed inpatients. Psychiatry Research 2007, 152:11-20.
30. Freemantle E., Chen G.G., Cruceanu C., Mechawar N., Turecki G. Analysis of oxysterols and cholesterol in prefrontal cortex of suicides. The International Journal of Neuropsychopharmacology/Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2013, 16:1241-1249.
31. Garland M.R., Hallahan B., McNamara M., Carney P.A., Grimes H., Hibbeln J.R., Harkin A., Conroy R.M. Lipids and essential fatty acids in patients presenting with self-harm. The British Journal of Psychiatry: The Journal of Mental Science 2007, 190:112-117.
32. Gietl A., Giegling I., Hartmann A.M., Schneider B., Schnabel A., Maurer K., Möller H.-J., Rujescu D. ABCG1 gene variants in suicidal behavior and aggression-related traits. European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology 2007, 17:410-416.
33. Gonçalves C.A., Leite M.C., Guerra M.C. Adipocytes as an important source of serum S100B and possible roles of this protein in adipose tissue. Cardiovascular Psychiatry and Neurology 2010, 2010:790431.
34. Gonçalves C.-A., Leite M.C., Nardin P. Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clinical Biochemistry 2008, 41:755-763.
35. Guillem E., Pélissolo A., Notides C., Lépine J.-P. Relationship between attempted suicide, serum cholesterol level and novelty seeking in psychiatric in-patients. Psychiatry Research 2002, 112:83-88.
36. Gupta A., Guyomard V., Zaman M.J.S., Rehman H.U., Myint P.K. Systematic review on evidence of the effectiveness of cholesterol-lowering drugs. Advances in Therapy 2010, 27:348-364.
37. Harrison A.A., Everitt B.J., Robbins T.W. Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms. Psychopharmacology 1997, 133:329-342.
38. Hawton K., Saunders K.E.A., O'Connor R.C. Self-harm and suicide in adolescents. Lancet 2012, 379:2373-2382.
39. Hayashi H. Lipid metabolism and glial lipoproteins in the central nervous system. Biological & Pharmaceutical Bulletin 2011, 34:453-461.
40. Hibbeln J.R., Salem N. Risks of cholesterol-lowering therapies. Biological Psychiatry 1996, 40:686-687.
41. Huang T., Wu S. Serum cholesterol levels in paranoid and non-paranoid schizophrenia associated with physical violence or suicide attempts in Taiwanese. Psychiatry Research 2000, 96:175-178.
42. Huang T.-L. Serum lipid profiles in major depression with clinical subtypes, suicide attempts and episodes. Journal of Affective Disorders 2005, 86:75-79.
43. Iwata A., Browne K.D., Chen X.-H., Yuguchi T., Smith D.H. Traumatic brain injury induces biphasic upregulation of ApoE and ApoJ protein in rats. Journal of Neuroscience Research 2005, 82:103-114.
44. Jafurulla M., Tiwari S., Chattopadhyay A. Identification of cholesterol recognition amino acid consensus (CRAC) motif in G-protein coupled receptors. Biochemical and Biophysical Research Communications 2011, 404:569-573.
45. Kamali M., Oquendo M.A., Mann J.J. Understanding the neurobiology of suicidal behavior. Depression and Anxiety 2001, 14:164-176.
46. Kaplan J.R., Muldoon M.F., Manuck S.B., Mann J.J. Assessing the observed relationship between low cholesterol and violence-related mortality. implications for suicide risk. Annals of the New York Academy of Sciences 1997, 836:57-80.
47. Kim Y.-K., Lee H.-J., Kim J.-Y., Yoon D.-K., Choi S.-H., Lee M.-S. Low serum cholesterol is correlated to suicidality in a Korean sample. Acta Psychiatrica Scandinavica 2002, 105:141-148.
48. Kim Y.-K., Myint A.-M. Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. Journal of Affective Disorders 2004, 81:161-166.
49. Kong M.M.C., Hasbi A., Mattocks M., Fan T., O'Dowd B.F., George S.R. Regulation of D1 dopamine receptor trafficking and signaling by caveolin-1. Molecular Pharmacology 2007, 72:1157-1170.
50. Korinek M., Kapras V., Vyklicky V., Adamusova E., Borovska J., Vales K., Stuchlik A., Horak M., Chodounska H., Vyklicky L. Neurosteroid modulation of N-methyl-d-aspartate receptors: molecular mechanism and behavioral effects. Steroids 2011, 76:1409-1418.
51. Kunugi H., Takei N., Aoki H., Nanko S. Low serum cholesterol in suicide attempters. Biological Psychiatry 1997, 41:196-200.
52. Lajoie P., Nabi I.R. Regulation of raft-dependent endocytosis. Journal of Cellular and Molecular Medicine 2007, 11:644-653.
53. Lalovic A., Levy E., Luheshi G., Canetti L., Grenier E., Sequeira A., Turecki G. Cholesterol content in brains of suicide completers. The International Journal of Neuropsychopharmacology/Official ScientificJournal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007, 10:159-166.
54. Lalovic A., Merkens L., Russell L., Arsenault-Lapierre G., Nowaczyk M.J.M., Porter F.D., Steiner R.D., Turecki G. Cholesterol metabolism and suicidality in Smith-Lemli-Opitz syndrome carriers. The American Journal of Psychiatry 2004, 161:2123-2126.
55. Lee B.-H., Kim Y.-K. Potential peripheral biological predictors of suicidal behavior in major depressive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2011, 35:842-847.
56. Lee H.-J., Kim Y.-K. Serum lipid levels and suicide attempts. Acta Psychiatrica Scandinavica 2003, 108:215-221.
57. Leoni V., Caccia C. Oxysterols as biomarkers in neurodegenerative diseases. Chemistry and Physics of Lipids 2011, 164:515-524.
58. Lester D. Serum cholesterol levels and suicide: a meta-analysis. Suicide & Life-Threatening Behavior 2002, 32:333-346.
59. Lindberg G., Råstam L., Gullberg B., Eklund G.A. Low serum cholesterol concentration and short term mortality from injuries in men and women. BMJ (Clinical Research Ed.) 1992, 305:277-279.
60. Liperoti R., Landi F., Fusco O., Bernabei R., Onder G. Omega-3 polyunsaturated fatty acids and depression: a review of the evidence. Current Pharmaceutical Design 2009, 15:4165-4172.
61. Lovisi G.M., Santos S.A., Legay L., Abelha L., Valencia E. [Epidemiological analysis of suicide in Brazil from 1980 to 2006]. Revista Brasileira de Psiquiatria (São Paulo, Brazil: 1999) 2009, 31(Suppl 2):S86-S94.
62. Magnani F., Tate C.G., Wynne S., Williams C., Haase J. Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin. The Journal of Biological Chemistry 2004, 279:38770-38778.
63. Manfredini R., Caracciolo S., Salmi R., Boari B., Tomelli A., Gallerani M. The association of low serum cholesterol with depression and suicidal behaviours: new hypotheses for the missing link. The Journal of International Medical Research 2000, 28:247-257.
64. Mann J.J., Emslie G., Baldessarini R.J., Beardslee W., Fawcett J.A., Goodwin F.K., Leon A.C., Meltzer H.Y., Ryan N.D., Shaffer D., Wagner K.D. ACNP Task Force report on SSRIs and suicidal behavior in youth. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2006, 31:473-492.
65. Marcinko D., Marcinko V., Karlović D., Marcinko A., Martinac M., Begić D., Jakovljević M. Serum lipid levels and suicidality among male patients with schizoaffective disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2008, 32:193-196.
66. Martinowich K., Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2008, 33:73-83.
67. Moutzouri E., Elisaf M., Liberopoulos E.N. Hypocholesterolemia. Current Vascular Pharmacology 2011, 9:200-212.
68. Muldoon M.F., Manuck S.B., Matthews K.A. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ (Clinical Research Ed.) 1990, 301:309-314.
69. Muldoon MF, Manuck SB, Mendelsohn AB, Kaplan JR, Belle SH Cholesterol reduction and non-illness mortality: meta-analysis of randomised clinical trials. BMJ 2001, 322(7277):11-15.
70. Nakamura H., Arakawa K., Itakura H., Kitabatake A., Goto Y., Toyota T., Nakaya N., Nishimoto S., Muranaka M., Yamamoto A., Mizuno K., Ohashi Y. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 2006, 368:1155-1163. MEGA Study Group.
71. Nathan P.J., O'Neill B.V., Napolitano A., Bullmore E.T. Neuropsychiatric adverse effects of centrally acting antiobesity drugs. CNS Neuroscience & Therapeutics 2011, 17:490-505.
72. Neaton J.D., Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Archives of Internal Medicine 1992, 152:56-64.
73. Park Y.-M., Lee B.-H., Lee S.H. The association between serum lipid levels, suicide ideation, and central serotonergic activity in patients with major depressive disorder. Journal of Affective Disorders 2014, 159:62-65.
74. Parton R.G., Richards A.A. Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic (Copenhagen, Denmark) 2003, 4:724-738.
75. Partonen T., Haukka J., Virtamo J., Taylor P.R., Lönnqvist J. Association of low serum total cholesterol with major depression and suicide. The British Journal of Psychiatry: The Journal of Mental Science 1999, 175:259-262.
76. Patel V., Ramasundarahettige C., Vijayakumar L., Thakur J.S., Gajalakshmi V., Gururaj G., Suraweera W., Jha P. Suicide mortality in India: a nationally representative survey. Lancet 2012, 379:2343-2351.
77. Pfrieger F.W., Ungerer N. Cholesterol metabolism in neurons and astrocytes. Progress in Lipid Research 2011, 50:357-371.
78. Phillips M.R., Cheng H.G. The changing global face of suicide. Lancet 2012, 379:2318-2319.
79. Pike L.J. Lipid rafts: bringing order to chaos. Journal of Lipid Research 2003, 44:655-667.
80. Pike L.J. The challenge of lipid rafts. Journal of Lipid Research 2009, 50:S323-S328. (Suppl).
81. Pi-Sunyer F.X., Aronne L.J., Heshmati H.M., Devin J., Rosenstock J. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 2006, 295:761-775. RIO-North America Study Group.
82. Pitman A., Krysinska K., Osborn D., King M. Suicide in young men. Lancet 2012, 379:2383-2392.
83. Pompili M., Serafini G., Innamorati M., Möller-Leimkühler A.M., Giupponi G., Girardi P., Tatarelli R., Lester D. The hypothalamic-pituitary-adrenal axis and serotonin abnormalities: a selective overview for the implications of suicide prevention. European Archives of Psychiatry and Clinical Neuroscience 2010, 260:583-600.
84. Pucadyil T.J., Chattopadhyay A. Cholesterol modulates ligand binding and G-protein coupling to serotonin(1A) receptors from bovine hippocampus. Biochimica et Biophysica Acta 2004, 1663:188-200.
85. Reddy M.A., Li S.-L., Sahar S., Kim Y.-S., Xu Z.-G., Lanting L., Natarajan R. Key role of Src kinase in S100B-induced activation of the receptor for advanced glycation end products in vascular smooth muscle cells. The Journal of Biological Chemistry 2006, 281:13685-13693.
86. Romanov K., Hatakka M., Keskinen E., Laaksonen H., Kaprio J., Rose R.J., Koskenvuo M. Self-reported hostility and suicidal acts, accidents, and accidental deaths: a prospective study of 21,443 adults aged 25 to 59. Psychosomatic Medicine 1994, 56:328-336.
87. Roy A., Gonzalez B., Marcus A., Berman J. Serum cholesterol, suicidal behavior and impulsivity in cocaine-dependent patients. Psychiatry Research 2001, 101:243-247.
88. Schmitz G., Langmann T., Heimerl S. Role of ABCG1 and other ABCG family members in lipid metabolism. Journal of Lipid Research 2001, 42:1513-1520.
89. Schreurs B.G. The effects of cholesterol on learning and memory. Neuroscience and Biobehavioral Reviews 2010, 34:1366-1379.
90. Sebastião A.M., Colino-Oliveira M., Assaife-Lopes N., Dias R.B., Ribeiro J.A. Lipid rafts, synaptic transmission and plasticity: impact in age-related neurodegenerative diseases. Neuropharmacology 2013, 64:97-107.
91. Seneviratne S.L., Warnasooriya W.M., Gunatilake S.B., Fonseka M.M., Gunawardena M.K., de Silva H.J Serum cholesterol concentrations in parasuicide. The Ceylon Medical Journal 1999, 44:11-13.
92. Simons K., Toomre D. Lipid rafts and signal transduction. Nature Reviews. Molecular Cell Biology 2000, 1:31-39.
93. 1A receptor-mediated signaling in human primary neuronal cultures. Naunyn-Schmiedeberg's Archives of Pharmacology 2008, 378:441-446.
94. Smith G.D., Shipley M.J., Marmot M.G., Rose G. Plasma cholesterol concentration and mortality. The Whitehall Study. JAMA: The journal of the American Medical Association 1992, 267:70-76.
95. Steiner J., Bogerts B., Schroeter M.L., Bernstein H.-G. S100B protein in neurodegenerative disorders. Clinical Chemistry and Laboratory Medicine: CCLM/FESCC 2011, 49:409-424.
96. Steiner J., Schiltz K., Walter M., Wunderlich M.T., Keilhoff G., Brisch R., Bielau H., Bernstein H.-G., Bogerts B., Schroeter M.L., Westphal S. S100B serum levels are closely correlated with body mass index: an important caveat in neuropsychiatric research. Psychoneuroendocrinology 2010, 35:321-324.
97. Steinert T., Woelfle M., Gebhardt R.P. No correlation of serum cholesterol levels with measures of violence in patients with schizophrenia and non-psychotic disorders. European Psychiatry: The Journal of the Association of European Psychiatrists 1999, 14:346-348.
98. Suzuki S., Kiyosue K., Hazama S., Ogura A., Kashihara M., Hara T., Koshimizu H., Kojima M. Brain-derived neurotrophic factor regulates cholesterol metabolism for synapse development. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2007, 27:6417-6427.
99. Suzuki S., Numakawa T., Shimazu K., Koshimizu H., Hara T., Hatanaka H., Mei L., Lu B., Kojima M. BDNF-induced recruitment of TrkB receptor into neuronal lipid rafts: roles in synaptic modulation. The Journal of Cell Biology 2004, 167:1205-1215.
100. Tamosiunas A., Reklaitiene R., Radisauskas R., Jureniene K. Prognosis of risk factors and trends in mortality from external causes among middle-aged men in Lithuania. Scandinavian Journal of Public Health 2005, 33:190-196.
101. Tanskanen A., Vartiainen E., Tuomilehto J., Viinamäki H., Lehtonen J., Puska P. High serum cholesterol and risk of suicide. The American Journal of Psychiatry 2000, 157:648-650.
102. Terrisse L., Séguin D., Bertrand P., Poirier J., Milne R., Rassart E. Modulation of apolipoprotein D and apolipoprotein E expression in rat hippocampus after entorhinal cortex lesion. Brain Research. Molecular Brain Research 1999, 70:26-35.
103. Tramontina A.C., Tramontina F., Bobermin L.D., Zanotto C., Souza D.F., Leite M.C., Nardin P., Gottfried C., Gonçalves C.-A. Secretion of S100B, an astrocyte-derived neurotrophic protein, is stimulated by fluoxetine via a mechanism independent of serotonin. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2008, 32:1580-1583.
104. Troisi A. Cholesterol in coronary heart disease and psychiatric disorders: same or opposite effects on morbidity risk?. Neuroscience and Biobehavioral Reviews 2009, 33:125-132.
105. Värnik P. Suicide in the world. International Journal of Environmental Research and Public Health 2012, 9:760-771.
106. Vevera J., Fisar Z., Kvasnicka T., Zdenek H., Stárková L., Ceska R., Papezová H. Cholesterol-lowering therapy evokes time-limited changes in serotonergic transmission. Psychiatry Research 2005, 133:197-203.
107. Vevera J., Zukov I., Morcinek T., Papezová H. Cholesterol concentrations in violent and non-violent women suicide attempters. European Psychiatry: The Journal of the Association of European Psychiatrists 2003, 18:23-27.
108. Vijayakumar L., Kumar M.S., Vijayakumar V. Substance use and suicide. Current Opinion in Psychiatry 2011, 24:197-202.
109. Virkkunen M., De Jong J., Bartko J., Linnoila M. Psychobiological concomitants of history of suicide attempts among violent offenders and impulsive fire setters. Archives of General Psychiatry 1989, 46:604-606.
110. Voulalas P.J., Schetz J., Undieh A.S. Differential subcellular distribution of rat brain dopamine receptors and subtype-specific redistribution induced by cocaine. Molecular and Cellular Neurosciences 2011, 46:645-654.
111. Vuksan-Cusa B., Marcinko D., Nad S., Jakovljević M. Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2009, 33:109-112.
112. Wang Yvan-Charvet L, Lütjohann D, Mulder M, Vanmierlo T, Kim TW, Tall AR ATP-binding cassette transporters G1 and G4 mediate cholesterol and desmosterol efflux to HDL and regulate sterol accumulation in the brain. FASEB Journal 2008, 22(4):1073-1082.
113. While A., Keen L. The effects of statins on mood: a review of the literature. European Journal of Cardiovascular Nursing: Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2012, 11:85-96.
114. Yip P.S.F., Caine E., Yousuf S., Chang S.-S., Wu K.C.-C., Chen Y.-Y. Means restriction for suicide prevention. Lancet 2012, 379:2393-2399.
115. Zhang J., Li Z. Suicide means used by Chinese rural youths: a comparison between those with and without mental disorders. The Journal of Nervous and Mental Disease 2011, 199:410-415.
116. Zhang J., Muldoon M.F., McKeown R.E., Cuffe S.P. Association of serum cholesterol and history of school suspension among school-age children and adolescents in the United States. American Journal of Epidemiology 2005, 161:691-699.